Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

Researchers Identify Multiple Molecules that Shut Down SARS-Cov-2 Polymerase Reaction
The Next Once-a-century Pandemic is Coming Sooner Than You Think – But COVID-19 Can Help Us Get Ready
Investigational Chimp Adenovirus MERS-CoV Vaccine Protects Monkeys

Health Security Today – 27 Feb 2020

by Global Biodefense Staff February 27, 2020, 1:00 am
Tulane National Primate Research Center Launches Coronavirus Research Program

by Global Biodefense Staff February 21, 2020, 11:52 am
Why It’s Important to Study Coronaviruses in African Bats

by Wanda Markotter, University of Pretoria February 19, 2020, 9:56 am
HHS and Sanofi Join Forces on Recombinant Technology for COVID-19 Vaccine

by Global Biodefense Staff February 18, 2020, 5:41 pm
J&J to Expand Partnership with HHS to Accelerate Discovery of COVID-19 Therapeutics

by Global Biodefense Staff February 18, 2020, 5:18 pm
Experts Say Cruise Ship Quarantine Pointless, Unjustified and Violates Human Rights

by Global Biodefense Staff February 18, 2020, 2:25 pm
The Legal Mess of Coronavirus Quarantine Across America’s 2,500+ Public Health Departments

by Global Biodefense Staff February 17, 2020, 7:39 am
WHO Director Fights to Prevent a Pandemic Without Offending China

by Global Biodefense Staff February 16, 2020, 10:03 am
The U.S. Has a Biodefense Strategy. It Just Isn’t Following It.

by Global Biodefense Staff February 16, 2020, 9:04 am
Emory, Collaborators Testing Antiviral Drug as Potential Treatment for Coronaviruses

by Global Biodefense Staff February 15, 2020, 5:19 pm
Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020

by Global Biodefense Staff February 14, 2020, 9:04 pm
Coronavirus Outbreak Puts ‘Open Science’ Under a Microscope

by Sabin Russell February 14, 2020, 9:52 am
Masks vs. Respirators: Experts Explain COVID-19 Recommendations

by Global Biodefense Staff February 13, 2020, 10:03 pm
Remdesivir Prevents MERS Coronavirus Disease in Monkeys

by Global Biodefense Staff February 13, 2020, 3:07 pm

Congratulations. You've reached the end of the internet.

Coronavirus

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

Researchers Identify Multiple Molecules that Shut Down SARS-Cov-2 Polymerase Reaction

The Next Once-a-century Pandemic is Coming Sooner Than You Think – But COVID-19 Can Help Us Get Ready

Investigational Chimp Adenovirus MERS-CoV Vaccine Protects Monkeys

Health Security Today – 27 Feb 2020

Tulane National Primate Research Center Launches Coronavirus Research Program

Why It’s Important to Study Coronaviruses in African Bats

HHS and Sanofi Join Forces on Recombinant Technology for COVID-19 Vaccine

J&J to Expand Partnership with HHS to Accelerate Discovery of COVID-19 Therapeutics

The Legal Mess of Coronavirus Quarantine Across America’s 2,500+ Public Health Departments

WHO Director Fights to Prevent a Pandemic Without Offending China

The U.S. Has a Biodefense Strategy. It Just Isn’t Following It.

Emory, Collaborators Testing Antiviral Drug as Potential Treatment for Coronaviruses

Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020

Coronavirus Outbreak Puts ‘Open Science’ Under a Microscope

Masks vs. Respirators: Experts Explain COVID-19 Recommendations

Remdesivir Prevents MERS Coronavirus Disease in Monkeys

Biodefense Headlines – 21 January 2021

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest stories

Latest Articles